Security key
76029N106
Replimune Group, Inc. - Common stock, par value $0.001 per share (REPL)
CUSIP: 76029N106
Q2 2022 13F Holders as of 30 Jun 2022
- Security type / class
- Equity / Common stock, par value $0.001 per share
- Total 13F shares
- 39,999,317
- Total 13F value
- $700,208,199
- Share change
- +1,007,569
- SEC-reported price per share
- $17.48
- Number of holders
- 98
- Value change
- +$17,983,844
- Number of buys
- 38
- Number of sells
- 48
- Shares outstanding
- 82,271,724
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2022
Institutions
98
Top holders
10
REPL full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2022
Previous quarter: Q1 2022
Replimune Group, Inc. SEC filings
Replimune Group, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 76029N106
Recent filing periods:
Ownership snapshot
Top reported holders of REPL - Replimune Group, Inc. - Common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PRICE T ROWE ASSOCIATES I...
Disclosed value leader
PRICE T ROWE ASSOCIATES I...
Comparable rows
15/15
Latest evidence
31 Mar 2022
13F
Lead comparable stake: 7.3%
Showing 1-6 of 15 holder rows.
Quick read
PRICE T ROWE ASSOCIATES INC /MD/ leads the comparable SEC ownership view at 7.3%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PRICE T ROWE ASSOCIATES INC /MD/'s linked filing trail.
Comparable ownership
Top 5
PRICE T ROWE ASSOCIATES INC /MD/
7.3%
Omega Fund Management, LLC
5.7%
Redmile Group, LLC
4.5%
Atlas Venture Life Science Adviso...
3.9%
BlackRock Finance, Inc.
2.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
7.3%
|
$102,266,000
6,022,760 shares
|
— | 31 Mar 2022 |
| Omega Fund Management, LLC |
13F
Company
|
5.7%
|
$79,354,000
4,673,380 shares
|
— | 31 Mar 2022 |
| Redmile Group, LLC |
13F
Company
|
4.5%
|
$62,678,000
3,691,312 shares
|
— | 31 Mar 2022 |
| Atlas Venture Life Science Advisors, LLC |
13F
Company
|
3.9%
|
$54,499,000
3,209,627 shares
|
— | 31 Mar 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
2.6%
|
$36,264,000
2,135,754 shares
|
— | 31 Mar 2022 |
| STATE STREET CORP |
13F
Company
|
2.1%
|
$29,070,000
1,712,037 shares
|
— | 31 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
98
Shares
39,999,317
Rows available
98
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
104
Q2 2022 holders
98
Holder diff
-6
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q2 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend